Screening for traditional risk factors for cardiovascular disease: A review for oral health care providers

Journal of the American Dental Association

Volumn 133, Issue 3, 2002, Pages 291-300

  Glick, Michael ^a  

^a RUTGERS NEW JERSEY MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHOLESTEROL;

ADULT; AGE; AGED; BLOOD; CARDIOVASCULAR DISEASE; CORONARY ARTERY DISEASE; DENTIST; DIABETES MELLITUS; FEMALE; FITNESS; GENETICS; GLUCOSE BLOOD LEVEL; HEALTH STATUS; HUMAN; HYPERTENSION; MALE; MASS SCREENING; MIDDLE AGED; OBESITY; PRIMARY PREVENTION; REVIEW; RISK ASSESSMENT; RISK FACTOR; SMOKING;

ADULT; AGE FACTORS; AGED; BLOOD GLUCOSE; CARDIOVASCULAR DISEASES; CHOLESTEROL; CORONARY DISEASE; DENTISTS; DIABETES COMPLICATIONS; FEMALE; HEALTH STATUS; HUMANS; HYPERTENSION; MALE; MASS SCREENING; MIDDLE AGED; OBESITY; PHYSICAL FITNESS; PRIMARY PREVENTION; RISK ASSESSMENT; RISK FACTORS; SMOKING;

EID: 0036518221     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2002.0168     Document Type: Article

References (79)

1. Anderson RN. United States life tables, 1998. National vital statistics report. Hyattsville, Md.: National Center for Health Statistics; 2001. U.S. Department of Health and Human Services.
2. American Heart Association. 2001 Heart and Stroke Statistical Update. Dallas: American Heart Association, 2001.
3. The long-term intervention with pravastatin in ischaemic disease (LIPID) study group: prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998;339:1349-57.
4. Cleland JG. Can improved quality of care reduce the costs of managing angina pectoris? Eur Heart J 1996;17(supplement 1):A29-A40.
5. Murray CJ, Lopez AD. Mortality by cause for eight regions of the world: global burden of disease study. Lancet 1997;349:1269-76.
6. Grundy SM, Balady GJ, Criqui MH, et al. Primary prevention of coronary heart disease: guidance from Framingham - a statement for healthcare professionals from the AHA Task Force on Risk Reduction. Circulation 1998;97:1876-87.
7. Glick M. New guidelines for prevention, detection, evaluation and treatment of high blood pressure. JADA 1998;129;1588-94.
8. Lloyd-Jones DM, Larson MG, Beiser A, Levy D. Lifetime risk of developing coronary heart disease. Lancet 1999;353:89-92.
9. Wilson PF, D'Agostino RB, Levy D, Belanger AM, Silbershatz H, Kannel WB. Prediction of coronary heart disease using risk factor categories. Circulation 1998;97:1837-47.
10. Stamler J, Stamler R, Neaton JD, et al. Low risk-factor profile and long-term cardiovascular and noncardiovascular mortality and life expectancy. JAMA 1999;282:2012-8.
11. Jousilahti P, Vartiainen E, Tuomilehto J, Puska P. Sex, age, cardiovascular risk factors, and coronary heart disease: a prospective follow-up study of 14,786 middle-aged men and women in Finland. Circulation 1999;99:1165-72.
12. Wannamethee G, Whincup PH, Shaper AG, Walker M, MacFarlane PW. Factors determining case fatality in myocardial infarction "who dies in a heart attack?" Brit Heart J 1995;74:324-31.
13. Centers for Disease Control and Prevention. Great American Smokeout: November 18, 1999. MMWR Morb Mortal Wkly Rep 1999;48:985-96.
14. Centers for Disease Control. Perspectives in disease prevention and health promotion: smoking-attributable mortality and years of potential life lost - United States, 1984. MMWR Morb Mortal Wkly Rep 1997;46:444-51.
15. Jee SH, Suh I, Kim IS, Appel LJ. Smoking and atherosclerotic cardiovascular disease in men with low levels of serum cholesterol. JAMA 1999;282:2149-55.
16. Hubert HB, Holford TR, Kannel WB. Clinical characteristics and cigarette smoking in relation to prognosis of angina pectoris in Framingham. Am J Epidemiol 1982;115:231-42.
17. Ockene JK, Kuller LH, Svendsen KH, Meilahn E. The relationship of smoking cessation to coronary heart disease and lung cancer in the Multiple Risk Factor Intervention Trial (MRFIT). Am J Public Health 1990;80:954-8.
18. Rosenberg L, Kaufman DW, Helmrich SP, Shapiro S. The risk of myocardial infarction after quitting smoking in men under 55 years of age. N Engl J Med 1985;313:1511-5.
19. Rosenberg L, Palmer JR, Shapiro S. Decline in the risk of myocardial infarction among women who stop smoking. N Engl J Med 1990;322:213-7.
20. National High Blood Pressure Education Program. The sixth report of the joint national committee on prevention, detection, evaluation, and treatment of high blood pressure. Bethesda, Md.: National Institutes of Health; 1997. NIH publication 98-4080.
21. Psaty BM, Smith NL, Siscovick DS, et al. Health outcomes associated with antihypertensive therapies used as first-line agents: a systematic review and meta-analysis. JAMA 1997;277:739-45.
22. Perreault S, Dorais M, Coupal L, Paradis G, Joffres MR, Grover SA. Impact of treating hyperlipidemia or hypertension to reduce the risk of death from coronary artery disease. CMAJ 1999;160:1449-55.
23. Ross R. Atherosclerosis: an inflammatory disease. N Engl J Med 1999;340:115-26.
24. Sun P, Dwyer KM, Merz C, et al. Blood pressure, LDL cholesterol, and intima-media thickness: a test of the "response to injury" hypothesis of atherosclerosis. Arterioscler Thromb Vasc Biol 2000;20:2005-10.
25. Poli KA, Tofler GH, Larson MG, et al. Association of blood pressure with fibrinolytic potential in the Framingham offspring population. Circulation 2000;101:264-9.
26. Sechi LA, Zingaro L, Catena C, Casaccio D, De Marchi S. Relationship of fibrinogen levels and hemostatic abnormalities with organ damage in hypertension. Hypertension 2000;36:978-85.
27. Lip GY, Blann AD, Jones AF, Lip PL, Beevers G. Relation of endothelium, thrombogenesis, and hemorheology in systemic hypertension to ethnicity and left ventricular hypertrophy. Am J Cardiol 1997;80:1566-71.
28. Lip GY. Target organ damage and the prothrombotic state in hypertension. Hypertension 2000;36:975-7.
29. Vogt M, Strauer BE. Systolic ventricular dysfunction and heart failure due to coronary microangiopathy in hypertensive heart disease. Am J Cardiol 1995;76:48D-53D.
30. Vasan RS, Larson MG, Kannel WB, Levy D. Evolution of hypertension from non-hypertensive blood pressure levels: rates of progression in the Framingham Heart Study (abstract 869-2). J Am Coll Cardiol 2000;35:292A.
31. Stamler J, Wentworth D, Neaton JD. Is relationship between serum cholesterol and risk of premature death from coronary heart disease continuous and graded? Findings in 356,222 primary screenees of the multiple risk factor intervention trial (MRFIT). JAMA 1986;256: 2823-8.
32. National Heart, Lung, and Blood Institute, National Cholesterol Education Program. Third report of the National Cholesterol Education Program (NCEP) Expert Panel: Detection, evaluation and treatment of high blood cholesterol in adults (Adult Treatment Panel III) executive summary. Bethesda, Md.: National Institutes of Health; 2001. NIH publication 01-3670.
33. Scandinavian Simvastatin Survival Group. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Lancet 1994;344: 1383-9.
34. Sacks FM, Pfeffer MA, Moye LA, et al. The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. N Engl J Med 1996;335:1001-9.
35. Shepherd J, Cobbe SM, Ford I, et al. Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia: West of Scotland Coronary Prevention Study Group. N Engl J Med 1995;333: 1301-7.
36. LaRosa JC, He J, Vupputuri S. Effect of statins on risk of coronary disease: a meta-analysis of randomized controlled trials. JAMA 1999;282:2340-6.
37. Downs JR, Clearfield M, Weis S, et al. Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS/TexCAPS (Air Force/Texas Coronary Atherosclerosis Prevention Study). JAMA 1998;279:1615-22.
38. The long-term intervention with pravastatin in ischaemic disease (LIPID) study group. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. N Engl J Med 1998;339:1349-57.
39. Wilson PW. High-density lipoprotein, low-density lipoprotein, and coronary artery disease. Am J Cardiol 1990;66:7A-10A.
40. Schaefer EJ, Lamon-Fava S, Ordovas JM, et al. Factors associated with low and elevated plasma high density lipoprotein cholesterol and apolipoprotein A-I levels in the Framingham offspring study. J Lipid Res 1994;35:871-82.
41. Boden WE, Pearson TA. Raising low levels of high-density lipoprotein cholesterol is an important target of therapy. Am J Cardiol 2000;85:645-50.
42. Kannel WB, McGee DL. Diabetes and glucose tolerance as risk factors for cardiovascular disease: the Framingham study. Diabetes Care 1979;2:120-6.
43. Folsom AR, Szklo M, Stevens J, Liao F, Smith R, Eckfeldt JH. A prospective study of coronary heart disease in relation to fasting insulin, glucose, and diabetes: the Atherosclerosis Risk in Communities (ARIC) Study. Diabetes Care 1997;20:935-42.
44. Haffner SM, Lehto S, Ronnemaa T, Pyorala K, Laakso M. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34.
45. Sowers JR. Diabetes mellitus and cardiovascular disease in women. Arch Intern Med 1998;158:617-21.
46. Balkau B, Bertrais S, Ducimetiere P, Eschwege E. Is there a glycemic threshold for mortality risk? Diabetes Care 1999;22:696-9.
47. Reaven GM. 1988 Banting lecture: role of insulin resistance in human disease. Diabetes 1988;37:1595-607.
48. Haffner SM. Management of dyslipidemia in adults with diabetes. Diabetes Care 1998;21:160-78.
49. Scherrer U, Sartori C. Insulin as a vascular and symphathoexcitatory hormone: implications for blood pressure regulation, insulin sensitivity, and cardiovascular morbidity. Circulation 1997;96:4104-13.
50. Sowers JR, Epstein M, Frohlich ED. Diabetes, hypertension, and cardiovascular disease: an update. Hypertension 2001;37:1053-9.
51. Timmis AD. Diabetic heart disease: clinical considerations. Heart 2001;85:463-9.
52. McBride PE. Is heart disease all in the family? Family history and cardiovascular disease. J Am Board Fam Pract 1996;9:382-3.
53. Phillips AN, Shaper AG, Pocock SJ, Walker M. Parental death from heart disease and risk of heart attack. Eur Heart J 1988;9:243-51.
54. Eaton CB, Bostom AG, Yanek L, et al. Family history and premature heart disease. J Am Board Fam Pract 1996;9:312-8.
55. Hunt SC, Williams RR, Barlow GK. A comparison of positive family history definitions for defining risk of future disease. J Chronic Dis 1986;39:809-21.
56. Myers RH, Kiely DK, Cupples LA, Kannel WB. Parental history as an independent risk factor for coronary artery disease: the Framingham study. Am Heart J 1990;120:963-9.
57. Becker DM, Yook RM, Moy TF, Blumenthal RS, Becker LC. Markedly high prevalence of coronary risk factors in apparently healthy African-American and white siblings of persons with premature coronary heart disease. Am J Cardiol 1998;82:1046-51.
58. Yanek LR, Moy TF, Blumenthal RS, et al. Hypertension among siblings of persons with premature coronary heart disease. Hypertension 1998;32:123-8.
59. Stary HC. Changes in components and structure of atherosclerotic lesions developing from childhood to middle age in coronary arteries. Basic Res Cardiol 1994;89(supplement 1):17-32.
60. Zureik M, Touboul PJ, Bonithon-Kopp C, Courbon D, Ruelland I, Ducimetiere P. Differential association of common carotid intimamedia thickness and carotid atherosclerotic plaques with parental history of premature death from coronary heart disease: the EVA study. Arterioscler Thromb Vase Biol 1999;19:366-71.
61. Almog DM, Illig KA, Khin M, Green RM. Unrecognized carotid artery stenosis discovered by calcifications on a panoramic radiograph. JADA 2000;131:1593-7.
62. Friedlander AH, Altman L. Carotid artery atheromas in post-menopausal women: their prevalence on panoramic radiographs and their relationship to atherogenic risk factors. JADA 2001;132:1130-6.
63. National Heart, Lung, and Blood Institute Obesity Education Initiative Panel. Clinical guidelines on identification, evaluation, and treatment of overweight and obesity in adults: The evidence report. Bethesda, Md.: National Institutes of Health; 1998. NIH publication 98-4083.
64. Bao W, Srinivasan SR, Valdez R, Greenlund KJ, Wattigney WA, Berenson GS. Longitudinal changes in cardiovascular risk from childhood to young adulthood in offspring of parents with coronary artery disease: the Bogalusa Heart Study. JAMA 1997;278:1749-54.
65. Manson JE, Willet WC, Stampfer MJ, et al. Body weight and mortality among women. N Engl J Med 1995;333:677-85.
66. Eckel RH, Krauss RM. American Heart Association call to action: obesity as a major risk factor for coronary heart disease. Circulation 1998;97;2099-100.
67. Eckel RH. Obesity and heart disease. Circulation 1997;96: 3248-50.
68. Rimm EB, Stampfer MJ, Giovannuci E, et al. Body size and fat distribution as predictors of coronary heart disease among middle-age and older U.S. men. Am J Epidemiol 1995;141:1117-27.
69. Fletcher GF, Balady G, Blair SN, et al. Statement on exercise: benefits and recommendations for physical activity programs for all Americans - a statement for health professionals by the Committee on Exercise and Cardiac Rehabilitation of the Council on Clinical Cardiology, American Heart Association. Circulation 1996;94:857-62.
70. U.S. Department of Health and Human Services. Physical activity and health: A report of the Surgeon General, 1996. Atlanta: Centers for Disease Control and Prevention.
71. Blair SN, Kohl HW III, Barlow CE, Paffenbarger RS Jr, Gibbons LW, Macera CA. Changes in physical fitness and all-cause mortality: a prospective study of healthy and unhealthy men. JAMA 1995;273: 1093-8.
72. Paffenbarger RS, Wing AL, Hyde RT. Physical activity as an index of heart attack risk in college alumni. Am J Epidemiol 1978;108:161-75.
73. Sesso HD, Paffenbarger RS Jr, Lee IM. Physical activity and coronary heart disease in men: the Harvard Alumni Health Study. Circulation 2000;102:975-80.
74. Lee IM, Sesso HD, Paffenbarger RS Jr. Physical activity and coronary heart disease in men: does the duration of exercise episodes predict risk? Circulation 2000;102:981-6.
75. Berlin JA, Colditz GA. A meta-analysis of physical activity in the prevention of coronary heart disease. Am J Epidemiol 1990;132:612-28.
76. Hakim AA, Curb JD, Petrovitch H, et al. Effects of walking on coronary heart disease in elderly men: the Honolulu Heart Program. Circulation 1999;100:9-13.
77. Kullo IJ, Gau GT, Tajik AJ. Novel risk factors for atherosclerosis. Mayo Clin Proc 2000;75:369-80.
78. Ridker PM. Evaluating novel cardiovascular risk factors: can we better predict heart attacks? Ann Intern Med 1999;130:933-7.
79. Armitage GC. Periodontal infections and cardiovascular disease: how strong is the association? Oral Dis 2000;6:335-50.